Recent Finacing
Recent Raise
Resolution Therapeutics develops macrophage-based cell therapies and manufacturing processes—combining macrophage biology, cell engineering, and clinical translation—to treat inflammatory organ damage, initially targeting end-stage chronic liver disease.
